RSI continues to conduct research into a method by which insulin can be delivered in a capsule or pouch containing our microbeads. Besides being able to deliver insulin orally, recent research indicates our technology may also be applied to other injectable-only drugs, such as tumor-killing cancer drugs. More focus will be placed on this very promising aspect in the coming months. On this oral insulin front, we have progressed forward with a large multinational pharmaceutical company that is interested in partnering with us to develop a finished product. We are expecting to receive a small number of raw materials to begin product testing in the very near future.